Integrative Tumor Board: Colon Cancer with Liver Metastases
نویسندگان
چکیده
منابع مشابه
Integrative tumor board: Advanced breast cancer.
1. The Challenge Recurrent breast cancer with post-surgery metastasis to bone (BCMB) is a problematic challenge to the medical field. Clinically, there has been no effective treatment or therapy available for this particular cancer condition. The first author has helped 18 cases of BCMB since his appointment as director of the National Qigong Anti-Cancer Research Project in China in the early 1...
متن کامل¹³¹I-MIBG scintigraphy in Carcinoid tumor with liver metastases (Case report) [Persian]
A 65 years old male presented with abdominal pain (R.U.Q) and constipation, associated with weight loss and anorexia since 40 days prior to admission. Serum biochemical tests were normal. Colonoscopy showed hemorrhagic polypoid lesion in the cecum. Barium enema revealed filling defect in the cecum. Sonography revealed a target-shaped lesion (3cm×2.5cm) in upper segment of the right hepati...
متن کاملLiver metastases of colon cancer. New therapeutic approaches. Neoadjuvant chemotherapy
Colon cancer witnesses one of most exciting and evolving times in the latest years. About 30% of patients with isolated liver colon metastases can now be cured through a multidisciplinary approach of the disease. New systemic treatments have moved the median survival of metastatic disease from 12 months four years ago to 20 months and beyond. Incorporation of new biologic treatments into the ne...
متن کاملColon carcinoma metastases with extension to chest wall and pericardium
Management of locally advanced colon cancer metastases is challenging and operation carries an increased risk of morbidity and mortality. The knowledge of exact sites of involvement can aid the surgeon to make a decision regarding complete resection or palliative therapy. PET/CT scan is an advantage in this setting because metabolic alterations often precede the anatomic changes; moreover, it c...
متن کاملGastrointestinal stromal tumor (GIST) with liver metastases
Approximately 40% to 50% of gastrointestinal stromal tumor (GIST) patients will have recurrence or metastases after resection of the primary lesion, and the most common affected sites will be liver and peritoneum. Imatinib has been considered as the first-line therapy of metastatic GIST. Surgery for metastases is proposed when possible. Furthermore, there are controversies concerning hepatic re...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Integrative Cancer Therapies
سال: 2003
ISSN: 1534-7354,1552-695X
DOI: 10.1177/1534735403002002019